Concepedia

Boris Blechacz

BB

18

Publications

1.3K

Citations

16

H-Index

2001

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Mayo Clinic in Arizona

Mayo Clinic

Virginia Commonwealth University

The University of Texas Health Science Center at Houston

Boris Blechacz is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, hepatology, and liver physiology.

Top concepts

Publications per year

2001–2019

18

Publications

18

Endoscopic and Histologic Features of Immune Checkpoint Inhibitor-Related Colitis

Yinghong Wang, Hamzah Abu‐Sbeih, Emily Mao et al. · Inflammatory Bowel Diseases · 2018 · 238 citations

Infected Cell Carriers: A New Strategy for Systemic Delivery of Oncolytic Measles Viruses in Cancer Virotherapy

Ianko Iankov, Boris Blechacz, Chunsheng Liu et al. · Molecular Therapy · 2006 · 133 citations · Full text

Sorafenib inhibits signal transducer and activator of transcription‐3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2†

Boris Blechacz, Rory L. Smoot, Steven F. Bronk et al. · Hepatology · 2009 · 114 citations · Full text

Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma

Boris Blechacz, Patrick L. Splinter, Suzanne Greiner et al. · Hepatology · 2006 · 109 citations

Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis

Dominique Thabut, Chittaranjan Routray, Gwen Lomberk et al. · Hepatology · 2011 · 97 citations · Full text

Rows per page

1–5 of 18